PRA Health Simplifies Treatment Decisions With Metys Launch
Zacks Investment Research | Sep 18, 2019 10:25PM ET
PRA Health Sciences, Inc. (NASDAQ:PRAH) recently launched Symphony Health’s national market measurement tool, known as Metys, in an effort to enhance its position and capabilities in the data and analytics field. Notably, the new tool is the only integrated all-in-one market research solution that is available from a contract research organization (CRO).
It is important to note here that in September 2017, PRA Health completed the acquisition of Symphony Health — a provider of data and analytics that enable companies to get an idea of the full market lifecycle of products offered for sale in the pharmaceutical industry.
Few Words about Metys
Being the first platform of its kind, Metys delivers pharmaceutical market analytics and intelligence in a timely and comprehensive manner. The tool integrates prescriber, payer and patient data assets, along with source of business, managed care and other key metrics. This provides a complete picture of market activity with excellent speed and precision. Notably, Metys is the only national market measurement solution that includes linked diagnosis subgroups to projected prescriptions and writers.
PRA Health Sciences Set to Gain
With each passing day, complete understanding, measuring and influencing treatment decisions are becoming crucial. With this new tool, the company expects cater to its clients more efficiently, while reinforcing its culture of innovation and excellence.
PRA Health, like other CROs, derive substantially all of its revenues from the research, development and marketing expenditures of the pharmaceutical, biotechnology and medical device industries. With worldwide increase in demand for outsourced clinical development solutions, the CRO industry is gaining rapid traction and popularity.
Market Prospects
Per a report by Zacks Investment Research
Get The News You Want
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.